IL286603A - Treatment employing anti-il-13r antibody or binding fragment thereof - Google Patents
Treatment employing anti-il-13r antibody or binding fragment thereofInfo
- Publication number
- IL286603A IL286603A IL286603A IL28660321A IL286603A IL 286603 A IL286603 A IL 286603A IL 286603 A IL286603 A IL 286603A IL 28660321 A IL28660321 A IL 28660321A IL 286603 A IL286603 A IL 286603A
- Authority
- IL
- Israel
- Prior art keywords
- antibody
- binding fragment
- treatment employing
- employing anti
- treatment
- Prior art date
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201902713S | 2019-03-26 | ||
| SG10201905063R | 2019-06-03 | ||
| SG10201907597W | 2019-08-16 | ||
| PCT/SG2020/050170 WO2020197502A1 (en) | 2019-03-26 | 2020-03-26 | Treatment employing anti-il-13r antibody or binding fragment thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL286603A true IL286603A (en) | 2021-10-31 |
Family
ID=70228774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL286603A IL286603A (en) | 2019-03-26 | 2021-09-22 | Treatment employing anti-il-13r antibody or binding fragment thereof |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210277131A1 (enExample) |
| EP (1) | EP3947457A1 (enExample) |
| JP (1) | JP2022528324A (enExample) |
| KR (1) | KR20210143788A (enExample) |
| CN (1) | CN113677708A (enExample) |
| AU (1) | AU2020247175A1 (enExample) |
| CA (1) | CA3134495A1 (enExample) |
| IL (1) | IL286603A (enExample) |
| SG (1) | SG11202109545VA (enExample) |
| WO (1) | WO2020197502A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022186773A1 (en) | 2021-03-01 | 2022-09-09 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION |
| WO2022186772A1 (en) | 2021-03-01 | 2022-09-09 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF |
| WO2023048651A1 (en) * | 2021-09-27 | 2023-03-30 | Aslan Pharmaceuticals Pte Ltd | Method for treatment of moderate to severe atoptic dematitis |
| WO2023048650A1 (en) * | 2021-09-27 | 2023-03-30 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF |
| TW202332466A (zh) * | 2021-10-29 | 2023-08-16 | 新加坡商亞獅康私人有限公司 | 抗ｉｌ－１３ｒ抗體調配物 |
| WO2023075702A1 (en) * | 2021-10-29 | 2023-05-04 | Aslan Pharmaceuticals Pte Ltd | Anti-il-13r antibody formulation |
| US20250163165A1 (en) * | 2022-02-23 | 2025-05-22 | Aslan Pharmaceuticals Pte Ltd | Glycosylated form of anti-il13r antibody |
| JP2025529908A (ja) * | 2022-08-26 | 2025-09-09 | アスラン ファーマシューティカルズ ピーティーイー リミテッド | 高濃度抗ｉｌ１３ｒ抗体製剤 |
| WO2025095864A1 (en) * | 2023-11-02 | 2025-05-08 | Aslan Pharmaceuticals Pte Ltd | Treatment |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| DK336987D0 (da) | 1987-07-01 | 1987-07-01 | Novo Industri As | Immobiliseringsmetode |
| GB8719042D0 (en) | 1987-08-12 | 1987-09-16 | Parker D | Conjugate compounds |
| GB8720833D0 (en) | 1987-09-04 | 1987-10-14 | Celltech Ltd | Recombinant dna product |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8907617D0 (en) | 1989-04-05 | 1989-05-17 | Celltech Ltd | Drug delivery system |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| ATE356869T1 (de) | 1990-01-12 | 2007-04-15 | Amgen Fremont Inc | Bildung von xenogenen antikörpern |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| CA2089661C (en) | 1990-08-29 | 2007-04-03 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| GB9112536D0 (en) | 1991-06-11 | 1991-07-31 | Celltech Ltd | Chemical compounds |
| GB9113120D0 (en) | 1991-06-18 | 1991-08-07 | Kodak Ltd | Photographic processing apparatus |
| GB9120467D0 (en) | 1991-09-26 | 1991-11-06 | Celltech Ltd | Anti-hmfg antibodies and process for their production |
| FR2716640B1 (fr) | 1994-02-28 | 1996-05-03 | Procedes Machines Speciales | Dispositif de centrage et de blocage d'une pièce en vue de son rodage à l'aide d'un rodoir à expansion. |
| ES2334408T3 (es) | 1995-10-23 | 2010-03-09 | Zenyth Operations Pty Ltd | Receptor de hematopoyetina y secuencias geneticas que lo codifican. |
| GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
| US6908963B2 (en) | 2001-10-09 | 2005-06-21 | Nektar Therapeutics Al, Corporation | Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith |
| CA2468950A1 (en) | 2001-11-27 | 2003-06-05 | Mochida Pharmaceutical Co., Ltd. | Anti-il13 receptor .alpha.1 neutralizing antibody |
| EP1576013A4 (en) | 2002-03-22 | 2008-08-13 | Amrad Operations Pty Ltd | MONOCLONAL ANTIBODY AGAINST THE INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13RA1) |
| DK1644412T4 (en) | 2003-07-01 | 2018-11-12 | Ucb Biopharma Sprl | MODIFIED ANTIBODY-FAB FRAGMENTS |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0411186D0 (en) | 2004-05-19 | 2004-06-23 | Celltech R&D Ltd | Biological products |
| GB0412181D0 (en) | 2004-06-01 | 2004-06-30 | Celltech R&D Ltd | Biological products |
| AR049390A1 (es) * | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
| TWI306862B (en) | 2005-01-03 | 2009-03-01 | Hoffmann La Roche | Antibodies against il-13 receptor alpha 1 and uses thereof |
| GB0619291D0 (en) | 2006-09-29 | 2006-11-08 | Ucb Sa | Altered antibodies |
| EP2068922B1 (en) * | 2006-10-19 | 2012-06-27 | CSL Limited | Anti-il-13r alpha 1 antibodies and their uses thereof |
| AU2007319604B2 (en) * | 2006-10-19 | 2011-03-24 | Csl Limited | High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| AR066240A1 (es) * | 2007-04-23 | 2009-08-05 | Wyeth Corp | Metodos y composiciones para tratar y monitorear el tratamiento de trastornos asociados con il-13 |
| CA2737241C (en) | 2008-09-26 | 2017-08-29 | Ucb Pharma S.A. | Multivalent antibody fusion proteins |
| WO2011017070A1 (en) * | 2009-07-28 | 2011-02-10 | Merck Sharp & Dohme Corp. | Methods for producing high concentration lyophilized pharmaceutical formulations |
| WO2016109822A1 (en) * | 2014-12-31 | 2016-07-07 | Novelmed Therapeutics, Inc. | Formulation of aglycosylated therapeutic antibodies |
| WO2019004943A1 (en) * | 2017-06-30 | 2019-01-03 | Aslan Pharmaceuticals Pte Ltd | METHOD OF TREATMENT USING ANTIBODY DIRECTED AGAINST IL-13R |
-
2020
- 2020-03-26 KR KR1020217032020A patent/KR20210143788A/ko active Pending
- 2020-03-26 US US17/272,243 patent/US20210277131A1/en active Pending
- 2020-03-26 CA CA3134495A patent/CA3134495A1/en active Pending
- 2020-03-26 WO PCT/SG2020/050170 patent/WO2020197502A1/en not_active Ceased
- 2020-03-26 AU AU2020247175A patent/AU2020247175A1/en active Pending
- 2020-03-26 JP JP2021556845A patent/JP2022528324A/ja active Pending
- 2020-03-26 EP EP20717992.0A patent/EP3947457A1/en active Pending
- 2020-03-26 CN CN202080022235.4A patent/CN113677708A/zh active Pending
- 2020-03-26 SG SG11202109545V patent/SG11202109545VA/en unknown
-
2021
- 2021-09-22 IL IL286603A patent/IL286603A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020247175A1 (en) | 2021-10-14 |
| EP3947457A1 (en) | 2022-02-09 |
| CN113677708A (zh) | 2021-11-19 |
| KR20210143788A (ko) | 2021-11-29 |
| SG11202109545VA (en) | 2021-10-28 |
| JP2022528324A (ja) | 2022-06-10 |
| WO2020197502A1 (en) | 2020-10-01 |
| CA3134495A1 (en) | 2020-10-01 |
| US20210277131A1 (en) | 2021-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286603A (en) | Treatment employing anti-il-13r antibody or binding fragment thereof | |
| IL277848A (en) | HER2-targeting antigen-binding molecules containing 4-1BBL | |
| IL263083A (en) | single chain variable segment cd3 binding proteins | |
| GB201905150D0 (en) | Ant-ige antibodies | |
| GB201901305D0 (en) | Specific binding molecules | |
| ZA202108836B (en) | Anti-epha4 antibody | |
| GB201802338D0 (en) | Antigen binding proteins | |
| IL291082A (en) | Anti-vsig4 antibody or antigen-binding fragment and uses thereof | |
| IL287555A (en) | binding compounds | |
| GB201919294D0 (en) | Antibodies or binding proteins | |
| GB201915282D0 (en) | Specific binding molecules | |
| IL288561A (en) | gal9-binding molecules with immunosuppressive activity | |
| ZA202005023B (en) | L2a5 antibody or functional fragment thereof against tumour antigens | |
| EP3269735A4 (en) | Anti-sclerostin antibody, antigen binding fragment and medical use thereof | |
| IL304317A (en) | tgf–beta–rii binding proteins | |
| IL291364A (en) | Antigen binding proteins | |
| GB201900732D0 (en) | Antibodies | |
| SG11201913540VA (en) | Anti-Podoplanin Antibody | |
| GB201906118D0 (en) | Anti-LAG-3 binding molecules | |
| GB201904328D0 (en) | Specific binding molecules | |
| ZA202200734B (en) | Binding members | |
| HK40068914A (en) | Treatment employing anti-il-13r antibody or binding fragment thereof | |
| GB201919062D0 (en) | Antibody | |
| GB201912657D0 (en) | Binding members | |
| GB201911931D0 (en) | Anti-C7 antibody or antibody fragment |